文献速递临床试验与 GCP

太极拳在非小细胞肺癌术后患者中的随机对照试验研究方案

Tai Chi Chuan in postsurgical non-small cell lung cancer patients: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2018-01-04

这是一项前瞻性、单中心、随机对照试验方案,计划纳入120例组织学确诊的I-IIIA期非小细胞肺癌完全手术切除后患者,随机分为太极拳训练组或安慰剂对照组。训练每次60分钟、每周3次、持续3个月,主要终点为峰值摄氧量(VO2peak),次要终点包括6分钟步行距离、健康相关生活质量、肺功能、免疫功能及抑郁焦虑状态,评估时间点为入组后第3、6、9、12个月。

要点

  • 太极拳训练每次60分钟、每周3次、持续3个月,目标强度为工作能力、呼吸困难和心率的60-80%。
  • 主要终点为峰值摄氧量(VO2peak),次要终点包括6分钟步行距离、健康相关生活质量、肺功能、免疫功能及抑郁焦虑状态。
  • 疗效与安全性评估时间点为入组后第3、6、9、12个月。

核心结论

  • 本试验将评估集体太极拳对非小细胞肺癌术后幸存者VO2peak、肺功能及其他方面的影响,并为太极拳作为运动训练应用于非小细胞肺癌全程患者提供临床证据及运动安全性可行性信息。

研究设计与样本

  • 前瞻性、单中心、随机对照试验,计划纳入120例组织学确诊的I-IIIA期非小细胞肺癌完全手术切除后患者。

主要发现

  • 原文为研究方案,未报告研究结果。

关键数值与推荐

  • 训练每次60分钟、每周3次、持续3个月。
  • 目标强度为工作能力、呼吸困难和心率的60-80%。
  • 主要终点为峰值摄氧量(VO2peak)。
  • 次要终点包括6分钟步行距离(6MWD)、健康相关生活质量(HRQoL)、肺功能、免疫功能及抑郁焦虑状态。
  • 评估时间点为入组后第3、6、9、12个月。

临床怎么用

  • 原文为研究方案,未提供临床实践推荐。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Impairment of exercise capacity remains a common adverse effect of non-small cell lung cancer (NSCLC) survivors after surgery. Previous research has suggested that Tai Chi Chuan (TCC) offers an exercise capacity benefit in several types of cancers. This is a randomized trial to investigate the efficacy and safety of TCC in postoperative NSCLC patients over an observation period of 3 months and a 9-month follow-up. METHODS/DESIGN: Using a prospective, one center and randomized design, 120 subjects with histologically confirmed stage I-IIIA NSCLC following complete surgical resection will potentially be eligible for this trial. Following baseline assessments, eligible participants will be randomly assigned to one of two conditions: (1) TCC training, or (2) placebo control. The training sessions for both groups will last 60 min and take place three times a week for 3 months. The sessions will be supervised with target intensity of 60-80% of work capacity, dyspnea, and heart rate management. The primary study endpoint is peak oxygen consumption (VO2peak), and the secondary endpoints include: 6-min walk distance (6MWD), health-related quality of life (HRQoL), lung function, immunity function, and the state of depression and anxiety. All endpoints will be assessed at the baseline and postintervention (3 months). A follow-up period of 9 months will be included. The main time points for the evaluation of clinical efficacy and safety will be months 3, 6, 9, and 12 after enrollment. DISCUSSION: This study will assess the effect of group TCC in postsurgery NSCLC survivors on VO2peak, lung function, and other aspects. The results of this study will eventually provide clinical proof of the application of TCC as one kind of exercise training for patients across the entire NSCLC continuum, as well as information on the safety and feasibility of exercise. TRIAL REGISTRATION: Chinese Clinical Trial Registry: ChiCTR-IOR-15006548 . Registered on 12 June 2015.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Pan H, Pei Y, Li B, et al. Tai Chi Chuan in postsurgical non-small cell lung cancer patients: study protocol for a randomized controlled trial. Trials. 2018. PMID: 29301544. doi:10.1186/s13063-017-2320-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。